Medeon Biodesign, Inc. (TPEX:6499)
Taiwan
· Delayed Price · Currency is TWD 81.80
-0.20 (-0.24%)
Apr 29, 2026, 1:30 PM CST
Medeon Biodesign Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -668.06 | -805.51 | -1,205 | -433.76 | 2,078 | Upgrade
|
| Depreciation & Amortization | 105.37 | 96.69 | 93.62 | 61.77 | 58.02 | Upgrade
|
| Other Amortization | 1.99 | 1.98 | 2.05 | 2.03 | 0.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 13.01 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.72 | 2.28 | 399.15 | -0.68 | -2,507 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | -13.54 | -47.69 | -19.66 | Upgrade
|
| Stock-Based Compensation | 13.68 | 9.73 | 15.69 | 3.11 | 5.95 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.07 | 13.41 | 0.58 | - | -0.36 | Upgrade
|
| Other Operating Activities | -50.48 | -145.65 | -89.68 | -76.96 | -2,607 | Upgrade
|
| Change in Accounts Receivable | -0.95 | -9.47 | -9.99 | 5.3 | 39.65 | Upgrade
|
| Change in Inventory | 9.26 | -23.33 | -0.71 | -4.4 | -10.04 | Upgrade
|
| Change in Accounts Payable | -4.45 | 6.64 | 1.42 | 2.87 | 4.42 | Upgrade
|
| Change in Unearned Revenue | 3.42 | 1.41 | 2.25 | 0.21 | -8.18 | Upgrade
|
| Change in Other Net Operating Assets | -37.28 | 19.18 | 35.7 | 26.86 | 36.56 | Upgrade
|
| Operating Cash Flow | -629.14 | -832.67 | -755.08 | -461.34 | -293.38 | Upgrade
|
| Capital Expenditures | -16.47 | -74.3 | -55.29 | -140.57 | -8.32 | Upgrade
|
| Cash Acquisitions | - | - | - | -165.89 | 4.21 | Upgrade
|
| Divestitures | - | - | - | - | 450.92 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.41 | -0.47 | -0.52 | -0.15 | -0.7 | Upgrade
|
| Investment in Securities | -4.78 | 209.92 | 1,643 | 552.91 | -535.92 | Upgrade
|
| Other Investing Activities | 0.16 | 0.06 | 8.64 | 17.13 | -0.83 | Upgrade
|
| Investing Cash Flow | -21.5 | 135.21 | 1,596 | 263.44 | -90.64 | Upgrade
|
| Long-Term Debt Repaid | -52.89 | -50.53 | -47.89 | -29.17 | -17.4 | Upgrade
|
| Total Debt Repaid | -52.89 | -50.53 | -47.89 | -29.17 | -17.4 | Upgrade
|
| Net Debt Issued (Repaid) | -52.89 | -50.53 | -47.89 | -29.17 | -17.4 | Upgrade
|
| Issuance of Common Stock | 3.77 | 3.85 | 0.23 | - | 10.1 | Upgrade
|
| Common Dividends Paid | - | - | -43.82 | -73.03 | - | Upgrade
|
| Other Financing Activities | 717.11 | - | 0.91 | 1.05 | 3.4 | Upgrade
|
| Financing Cash Flow | 667.98 | -46.68 | -90.57 | -101.16 | -3.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | -9.94 | 19.55 | 4.09 | 47.64 | -4.89 | Upgrade
|
| Net Cash Flow | 7.41 | -724.59 | 754.07 | -251.42 | -392.81 | Upgrade
|
| Free Cash Flow | -645.61 | -906.97 | -810.36 | -601.91 | -301.69 | Upgrade
|
| Free Cash Flow Margin | -153.93% | -309.75% | -412.90% | -201.77% | -437.51% | Upgrade
|
| Free Cash Flow Per Share | -6.99 | -9.84 | -8.80 | -6.54 | -3.28 | Upgrade
|
| Cash Interest Paid | 3.64 | 5.56 | 6.64 | 4.6 | 1.55 | Upgrade
|
| Cash Income Tax Paid | 2.31 | 86.81 | 59.94 | 69.21 | 4.35 | Upgrade
|
| Levered Free Cash Flow | -383.52 | -561.07 | -455.87 | -416.46 | -89.12 | Upgrade
|
| Unlevered Free Cash Flow | -381.22 | -557.6 | -451.72 | -413.2 | -88.48 | Upgrade
|
| Change in Working Capital | -29.99 | -5.59 | 28.67 | 30.84 | 62.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.